Emory University School of Medicine SC CTL019 — Atlanta, Georgia

Emory University School of Medicine SC CTL019 is a clinical research site located in Atlanta, Georgia, United States 30322.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Emory University School of Medicine SC CTL019 has participated in 1 clinical trials.

Therapeutic areas: Diffuse Large B-cell Lymphoma.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Emory University School of Medicine SC CTL019?

Emory University School of Medicine SC CTL019 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Emory University School of Medicine SC CTL019 conducted?

Emory University School of Medicine SC CTL019 has 1 clinical trials on record. Their work covers Diffuse Large B-cell Lymphoma.

Is Emory University School of Medicine SC CTL019 accredited by Crixeo Health?

Emory University School of Medicine SC CTL019 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Emory University School of Medicine SC CTL019?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.